BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36629029)

  • 1. Predictors of genetic risk recall among the participants of a randomized controlled precision prevention trial against melanoma.
    Lacson JCA; Kim Y; Roetzheim RG; Sutton SK; Vadaparampil ST; Kanetsky PA
    Genet Med; 2023 Apr; 25(4):100005. PubMed ID: 36629029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of melanoma precision prevention materials incorporating MC1R genetic risk information.
    Lacson JCA; Forgas SM; Doyle SH; Qian L; Del Rio J; Valavanis S; Carvajal R; Gonzalez-Calderon G; Kim Y; Roetzheim RG; Vadaparampil ST; Kanetsky PA
    Transl Behav Med; 2022 May; 12(5):683-687. PubMed ID: 35552458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of correct recall of genetic risk information among Hispanic individuals in Florida and Puerto Rico.
    Lacson JCA; Sutton SK; Kim Y; Roetzheim RG; Vadaparampil ST; Soto-Torres B; Kanetsky PA
    Patient Educ Couns; 2023 Dec; 117():107978. PubMed ID: 37708699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.
    Hay JL; Berwick M; Zielaskowski K; White KA; Rodríguez VM; Robers E; Guest DD; Sussman A; Talamantes Y; Schwartz MR; Greb J; Bigney J; Kaphingst KA; Hunley K; Buller DB
    JMIR Res Protoc; 2017 Apr; 6(4):e52. PubMed ID: 28442450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes.
    Lacson JCA; Doyle SH; Qian L; Del Rio J; Forgas SM; Valavanis S; Carvajal R; Gonzalez-Calderon G; Kim Y; Roetzheim RG; Sutton SK; Vadaparampil ST; Kanetsky PA
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of precision prevention materials incorporating
    Lacson JCA; Doyle SH; Del Rio J; Forgas SM; Carvajal R; Gonzalez-Calderon G; Feliciano AR; Kim Y; Roetzheim RG; Sutton SK; Vadaparampil ST; Soto-Torres B; Kanetsky PA
    Cancer Res Commun; 2022 Jan; 2(1):28-38. PubMed ID: 35845857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.
    Hay JL; Zielaskowski K; Meyer White K; Kaphingst K; Robers E; Guest D; Sussman A; Talamantes Y; Schwartz M; Rodríguez VM; Li Y; Schofield E; Bigney J; Hunley K; Buller D; Berwick M
    JAMA Dermatol; 2018 Jun; 154(6):684-693. PubMed ID: 29801061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.
    Glanz K; Volpicelli K; Kanetsky PA; Ming ME; Schuchter LM; Jepson C; Domchek SM; Armstrong K
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):607-14. PubMed ID: 23392000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
    Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marshaling the Translational Potential of
    Kanetsky PA; Hay JL
    Cancer Prev Res (Phila); 2018 Mar; 11(3):121-124. PubMed ID: 29246956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
    Smit AK; Newson AJ; Morton RL; Kimlin M; Keogh L; Law MH; Kirk J; Dobbinson S; Kanetsky PA; Fenton G; Allen M; Butow P; Dunlop K; Trevena L; Lo S; Savard J; Dawkins H; Wordsworth S; Jenkins M; Mann GJ; Cust AE
    Contemp Clin Trials; 2018 Jul; 70():106-116. PubMed ID: 29802966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivors.
    Wu YP; Stump TK; Hay JL; Aspinwall LG; Boucher KM; Deboeck PR; Grossman D; Mooney K; Leachman SA; Smith KR; Wankier AP; Brady HL; Hancock SE; Parsons BG; Tercyak KP
    Contemp Clin Trials; 2023 Aug; 131():107276. PubMed ID: 37393004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention and Evaluation of Precision and Generic Prevention Materials for Melanoma: A Qualitative Study Comparing Young Adults and Adults.
    Crowder SL; Buro AW; Lacson JCA; Kim Y; Sutton SK; Roetzheim RG; Vadaparampil ST; Stern M; Kanetsky PA
    Cancer Prev Res (Phila); 2022 Aug; 15(8):533-542. PubMed ID: 35665800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial.
    Smit AK; Allen M; Beswick B; Butow P; Dawkins H; Dobbinson SJ; Dunlop KL; Espinoza D; Fenton G; Kanetsky PA; Keogh L; Kimlin MG; Kirk J; Law MH; Lo S; Low C; Mann GJ; Reyes-Marcelino G; Morton RL; Newson AJ; Savard J; Trevena L; Wordsworth S; Cust AE
    Genet Med; 2021 Dec; 23(12):2394-2403. PubMed ID: 34385669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
    Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.